Facebook
Twitter
LinkedIn
Forward
CMHC Annual 2021 On Demand
The global epidemic of cardiometabolic disease demands the continual refinement of cardiometabolic care approaches and strategies. As the nation’s premier event in cardiometabolic medicine, the 16th Annual Cardiometabolic Health Congress
has been curated by the field’s leading experts to deliver to you the latest evidence-based interventions to improve health outcomes and quality of life for the growing numbers of patients at increased cardiometabolic risk.
This On Demand activity features recordings from this year's Pushing Boundaries in Cardiometabolic Health: Challenges and Controversies across four days of new late-breaking research, FDA updates, clinical insights, and more all delivered through an actionable lens.
There is a registration fee for this activity (if you were a live attendee please refer to the below note). Registration can be found here. Once registration is complete, you will receive a confirmation email with an access code and link back to this course.
If you attended the live meeting either live or virtually at the 2021 annual meeting, please reach out to info@cardiometabolichealth.org and we will provide you with complimentary access code to this activity.
Target Audience
US-based healthcare professionals, including cardiologists, endocrinologists, lipidologists, primary care clinicians (PCPs), registered nurses, advanced practice registered nurses, dieticians, pharmacists, and other allied health professionals.
Learning Objectives
After completing this activity, the participant should be better able to:
- Discuss the interrelationships among cardiometabolic risk factors and their impact on the development of cardiometabolic diseases, including diabetes, dyslipidemia, hypertension, obesity, kidney disease, and cardiovascular disease
- Interpret the latest evidence and guidelines for the prevention, screening, and treatment of the complex patient with cardiometabolic risk or cardiometabolic disease
- Outline strategies aimed at timely screening and prevention of cardiometabolic disease, assessment of risk factors and biomarkers, and lifestyle modifications
- Develop individualized treatment regimens for patients with cardiometabolic disease based on the efficacy and safety of current and new pharmacotherapies, patient comorbidities and preferences in order to optimize outcomes
- Summarize recent evidence for emerging therapies in order to stay current with the most recent updates in the cardiometabolic field
- Recognize the impacts of rare cardiometabolic diseases, including rare lipid, cardiovascular, diabetes, and obesity disorders, as well as potential implications for management
- Outline diagnostic and treatment regimens for cardiometabolic rare conditions based on the efficacy and safety of current, new, and emerging diagnostic and treatment modalities
- Interpret the evidence for the use of CGM in patients with type 2 diabetes, as well as important glycemic parameters that can inform treatment decisions beyond HbA1c
Robert H. Eckel, MD (Chair) | Christie M. Ballantyne, MD (Chair) |
George L. Bakris, MD (Chair) | Anne L. Peters, MD (Chair) |
Rajiv Agarwal, MD | Ola Akinboboye, MD |
Grazia Aleppo, MD, FACE, FACP | Vanita R. Aroda, MD Director, Diabetes Clinical Research Brigham and Women’s Hospital Harvard Medical School Boston, MA |
Louis J. Aronne, MD | Sonja Bartolome, MD, FCCP |
Harold E. Bays, MD | Deepak L. Bhatt, MD |
Rebecca J. Brown, MD | Matthew J. Budoff, MD |
Karli Burridge, PA-C, MMS, FOMA | Ruth Carrico, PhD, DNP, APRN Professor University of Louisville Louisville, KY |
| Stephen Devries, MD, FACC Executive Director Nonprofit Gaples Institute Deerfield, IL | Kathleen M. Dungan, MD, MPH Associate Professor, Division of Endocrinology, Diabetes & Metabolism Associate Director of Clinical Services, Division of Endocrinology, Diabetes & Metabolism The Ohio State University Columbus, OH |
| Clair A. Francomano, MD Professor of Medical & Molecular Genetics Indiana University School of Medicine Indianapolis, IN | Kevin D. Hall, PhD Section Chief: Integrative Physiology Section, Laboratory of Biological Modeling National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD |
| Joan C. Han, MD Professor of Pediatrics Chief of the Division of Pediatric Endocrinology and Diabetes, Jack and Lucy Clark Department of Pediatrics Icahn School of Medicine at Mount Sinai New York, NY | James O. Hill, PhD Professor and Chair, Department of Nutrition Sciences University of Alabama at Birmingham Birmingham, AL |
| Irl B. Hirsch, MD Professor of Medicine Diabetes Treatment and Teaching Chair University of Washington Medical Center Medical Director UWMC Diabetes Care Center Seattle, WA | Sandeep Jauhar, MD Author of Intern & Heart: A History |
| John L. Jefferies, MD, MPH Chief, Cardiovascular Diseases Methodist Healthcare/University of Tennessee Health Science Center Memphis, TN | Jay L. Koyner, MD Professor of Medicine University of Chicago Chicago, IL |
| Michelle Look, MD, FAAFP Family Practice-Sports Medicine Physician San Diego Sports Medicine and Family Health San Diego, CA | Christos S. Mantzoros, MD, DSc, PhD Professor of Medicine Harvard Medical School Boston, MA |
| Janet B. McGill, MD Professor of Medicine Washington University School of Medicine St. Louis, MO | Darren McGuire, MD, MHSc Professor of Internal Medicine University of Texas Southwestern Medical Center Parkland Health and Hospital System Dallas, TX |
Alanna A. Morris, MD, MSc | Pamela B. Morris, MD |
| Rochelle N. Naylor, MD Assistant Professor of Pediatrics, Medicine, University of Chicago Chicago, IL | Katrina L. Piercy, PhD, RD Acting Director, Division of Prevention Science Office of Disease Prevention and Health Promotion Rockville, MD |
| Bertram Pitt, MD Professor of Medicine, Emeritus University of Michigan School of Medicine Ann Arbor, MI | Gregory A. Poland, MD, MACP, FRCP Mary Lowell Leary Emeritus Professor of Medicine Distinguished Investigator, Mayo Clinic Director, Mayo Vaccine Research Group Editor-in-Chief, VACCINE Mayo Clinic Rochester, MN |
| Rodica Pop-Busui, MD, PhD Larry D. Soderquist Professor of Diabetes Professor of Internal Medicine, Metabolism and Diabetes Vice-Chair Clinical Research University of Michigan Ann Arbor, MI | Richard E. Pratley, MD Samuel E. Crockett Chair in Diabetes Research Medical Director, AdventHealth Diabetes Institute Senior Investigator and Diabetes Program Lead, AdventHealth Translational Research Institute; Adjunct Professor of Medicine, Johns Hopkins University School of Medicine AdventHealth Orlando, FL |
| Paul M. Ridker, MD, MPH Eugene Braunwald Professor of Medicine Harvard Medical School Director Center for Cardiovascular Disease Prevention Brigham and Women’s Hospital Boston, MA | Robert S. Rosenson, MD Professor of Medicine (Cardiology), Icahn School of Medicine at Mount Sinai Director of Metabolism and Lipids, Mount Sinai Health System Icahn School of Medicine at Mount Sinai New York, NY |
Karol E. Watson, MD, PhD, FACC | Kim A. Williams, Sr., MD |
Cameron R. Wolfe, MBBS | Holly Wyatt, MD |
| Bernard Zinman, OC, MDCM, FRCPC, FACP Stephen and Suzie Pustil Diabetes Research Scientist Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital Professor of Medicine, University of Toronto Toronto, ON, Canada |
ESTIMATED TIME TO COMPLETE ACTIVITY
18.25 hours
EDUCATIONAL GRANT SUPPORT
Annual 2021 On Demand is supported in part by educational grants from Kowa Pharmaceuticals America, Inc., Medtronic, and Rhythm Pharmaceuticals, Inc.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Tarsus Cardio Inc. dba Cardiometabolic Health Congress (CMHC). Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CONTINUING MEDICAL EDUCATION
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 18.25 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.
CONTINUING NURSING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 18.25 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.
CONTINUING PHARMACY EDUCATION
Postgraduate Institute for Medicine designates this continuing education activity for 18.25 contact hour(s) (1.825 CEUs) of the Accreditation Council for Pharmacy Education.
This is a knowledged-based activity. Universal Activity Numbers (UAN): # JA4008162-0000-21-140-H01-P.
For Pharmacists: Upon completing the post-test and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 – 6 weeks.
CONTINUING DIETICIAN EDUCATION
This program offers 18.25 CPEUs for dieticians.
ABIM MOC CERTIFICATION
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 18.25 MOC points in the American Board of Internal Medicine's (ABIM) maintenance of certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Faculty
A full listing of faculty disclosures 
can be downloaded here
Planners and Managers
The PIM planners and managers have nothing to disclose. The CMHC planners and managers have nothing to disclose.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
METHOD OF PARTICIPATION & REQUEST FOR CREDIT
There is a registration fee for this activity (if you were a live attendee please refer to the below note). Registration can be found here. Once registration is complete, you will receive a confirmation email with an access code and link back to this course.
If you attended the live meeting either live or virtually at the 2021 annual meeting, please reach out to info@cardiometabolichealth.org and we will provide you with complimentary access code to this activity.
During the period November 23, 2021 through November 23, 2022, participants must read the learning objectives and faculty disclosures, study the educational activity, and complete the evaluation. Upon completing, your certificate will be available for print. For questions about receiving certificates, please contact us at CMHC_Eval@cardiometabolichealth.org.
For questions about the accreditation of this activity, please contact PIM via email at inquiries@pimed.com.
For Pharmacists: Please complete the evaluation instructions above. Upon registering and completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service within 4-6 weeks.
Available Credit
- 18.25 ACPE Pharmacy
- 18.25 AMA PRA Category 1 Credit™
- 18.25 ANCC
- 18.25 CDE
- 18.25 Participation
There is a registration fee for this activity (if you were a live attendee please refer to the below note). Registration can be found here. Once registered, you will receive a confirmation email with an access code and link back to this course. Please enroll and proceed with the course instructions.
Complimentary access for all live attendees of the 2021 Annual meeting: If you attended the live meeting either live or virtually at the 2021 annual meeting, please reach out to info@cardiometabolichealth.org and we will provide you with complimentary access code to this activity.
Required Hardware/software
A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.